• Home
  • Media
  • Press Releases

Press Releases

The UAE first pharmaceutical manufacturer Julphar commemorates its 40th anniversary

The organisation plans to continue their legacy of creating a safe space for trust, innovation, and transformation by providing advanced health security across the region
Julphar Q3

Gulf Pharmaceutical Industries Julphar maintains sales growth after successful market reentry across GCC

- Julphar announces a 10% increase in sales compared to Q2 2020 - Company continues transformational journey with strategic turnaround on track

Gulf Pharmaceutical Industries Julphar Reports Financial Results for Q2 2020

- Julphar announces 90% increase in sales in comparison to Q2 2019 - Strong result improvement with 6% EBITDA margin in Q2 2020

Gulf Pharmaceutical Industries (Julphar) rights issue oversubscribed by 2.3 times

- Julphar launched AED 500 million rights issue at an offer price of AED 1 per share on 29th June 2020 - Total bids received from existing rightsholders stood at AED 1.14 billion on application which closed on 12th July 2020
This website intends to use cookies to improve the site and your experience. By continuing to browse the site you are agreeing to accept our use of cookies. If you require further information and/or do not wish to have cookies placed when using the site, refer to our Cookie Policy.